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DObjective: Acute type A aortic syndromes and its chronic complications are fatal diseases traditionally treated
by open surgery, with high mortality rates. An endovascular approach to the ascending aorta could reduce the
morbidity and mortality associated with open surgery. Our aim was to report our initial experience in treating
ascending aortic pathology using commercially available descending thoracic endografts.
Methods: From 2007 to 2012, 69 patients presented to our center in Belo Horizonte, Brazil, with acute type A
aortic syndrome or its chronic complications. Of the 69 patients, 8 high-risk patients had suitable anatomy,
and 7 agreed to participate in the present study.
Results:Of the 7 patients, 4 had penetrating ulcers, 2 had acute dissections, and 1 had chronic dissection with an
aneurysm. The technical success rate was 87%, with 1 intraoperative death from acute aortic valve insufficiency.
The proximal landing zone was, on average, 21 mm above the aortic valve in all patients. Three patients required
intraoperative cervical debranching due to a lesion in the distal third of the ascending aorta, compromising the
supra-aortic branches. The distal landing zone was at zone 0 in 4 patients, zone 2 in 1 patient, and in zone 4 in
2 patients. The mean follow-up was 26.3 months. Two repeat dissections developed an average of 2 months after
treatment. Both presented with acute dissection that was treated with additional open surgery and both patients
survived. Thereafter, no patient had presented again with an acute aortic syndrome or other referable symptoms.
Conclusions: Endovascular treatment of the ascending aorta is feasible. We had 4 good mid-term results in
7 patients who had presented with penetrating ulcers or aneurysm formation. Acute dissections seem to be
more unstable, and additional research is mandatory. (J Thorac Cardiovasc Surg 2014;148:105-12)Acute aortic syndromes are a heterogeneous group of di-
seases that include aortic dissection, intramural hematomas,
and penetrating ulcers. Chronically, these syndromes can
lead to aneurysm formation and rupture. Although each of
these entities has distinct pathophysiologic features and
radiologic findings, some overlap exists.1,2 In particular,
all these entities share a common Stanford A classifi-
cation and similar clinical presentation, eg, chest pain
associated with severe arterial hypertension.1,2 Acute
aortic type A dissection has traditionally been treated with
open surgery by way of a median sternotomy and
cardiopulmonary bypass. However, open surgery for acute
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The Journal of Thoracic and Caand mortality, even for experienced surgeons, with
reported mortality rates of up to 60%3 and stroke rates of
up to 18%.4,5
The advent of improved endovascular techniques and
devices has facilitated recent advances in the management
of thoracic aortic pathologic entities.1 The ascending aorta
and aortic arch, with its supra-aortic branches, has become
an area of controversy, with many groups attempting
endovascular repair using different strategies. The optimal
method has still not been established. The ascending aorta
is challenging to treat using endovascular techniques owing
to its short length and location close to the aortic valve,
coronary arteries, and the arch with its supra-aortic
branches.3,6
The ascending aorta has generally been designated as
zone 0 and can be further subdivided into thirds according
to Lu and colleagues6: (1) proximal, including the aortic
root (valve and coronaries ostia), sinotubular junction,
and proximal one third of the tubular portion of the
ascending aorta; (2) middle, not having any branches,
corresponding to the middle third of the tubular portion of
the ascending aorta, and the most suitable location for
endovascular treatment; and (3) distal, corresponding to
the distal third of the tubular portion of the ascending aorta
and reaching the proximal border of the innominate artery,rdiovascular Surgery c Volume 148, Number 1 105
Abbreviation and Acronym
CT ¼ computed tomography
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hybrid technique to expand the landing zone and preserve
perfusion to the arch and branches.6 The options for hybrid
approaches for treatment in the distal zone 0 include the
debranching technique, which still requires opening the
chest wall, with the associated high rates of morbidity
and mortality,5 and the carotid–carotid bypass technique,
with or without adjunctive carotid–left subclavian artery
bypass.
Currently there is great interest in the newer generations
of branched or fenestrated devices that enable an endovas-
cular approach to these proximal aortic pathologic entities,
potentially avoiding major surgery in severely ill patients.5,7
Several reports have begun to describe investigators’
initial experiences with the newer devices, with dedicated
designs especially modified for the ascending aorta
to treat aneurysms, pseudoaneurysms, ulcers, intramural
hematoma, and type A dissection.3,6 However, these
newer generation devices are only available for a small
number of centers and are not available for most patients.5
We report our initial experience treating patients with
ascending aortic zone 0 pathology using commercially
available descending thoracic endografts to avoid tradi-
tional open surgery requiring thoracotomy and branched
or fenestrated devices.METHODS
From 2007 to 2012, 69 patients presented to the Madre Teresa Hospital
Aortic Center, Belo Horizonte (Minas Gerais, Brazil) with acute aortic
syndrome due to pathology in the ascending aorta or with aneurysmal
degeneration as a chronic complication after an acute aortic syndrome.
Of these 69 patients, 8 were considered at high risk for open surgery by
a multidisciplinary team composed of surgeons, cardiologists, and anesthe-
siologists. One or more of the following criteria were considered to indicate
high risk for open repair at surgery: age>70 years, severe coronary artery
disease, previous surgery with cardiopulmonary bypass, and/or severe
chronic obstructive pulmonary disease with ambulatory oxygen use. These
patients were offered the opportunity for endovascular repair as an alterna-
tive to open surgery. The anatomic inclusion criteria were as follows:
1. Presence of distinct proximal and distal landing zones
2. Absence of aortic valve insufficiency or pericardial effusion
3. Site of the entry tear of the acute aortic syndrome in the middle and
distal third of the ascending aorta (all above the sinotubular junction)
4. Absence of the signs of ischemia of the supra-aortic branches
5. Absence of ventricular arrhythmia
6. Absence of a connective tissue disorder
7. Adequate femoral and iliac arteries
8. Able to give informed consent for the endovascular procedure
The computed tomographic (CT) angiograms before the intervention
were analyzed using OsiriX software, version 4.1.2, for Mac (Pixmeo,
Bernex, Switzerland) to identify the anatomic morphology of the aorta
and its branches and the site of the entrance tear. The center lumen line106 The Journal of Thoracic and Cardiovascular Surgwas generated, the distances between the lesion and the aortic valve and
supra-aortic vessels and the length of the ascending aorta were measured.
Stent graft selection was determined by the ascending aortic length and the
diameter measured immediately above the sinotubular junction (proximal
landing zone at the tubular portion of the ascending aorta). In patients with
lesions in the distal third of the ascending aorta, a cervical debranching
approach was planned to extend the landing zone and preserve perfusion
to the supra-aortic branches.
All thoracic endovascular aneurysm repair devices were commercially
available for treatment of the descending aorta. No device had either
branches or fenestrations, and no device was specifically designed for
ascending aorta. Also, no device was modified specifically for any patient.
All patients received general anesthesia. After exposure of the best
suitable femoral artery, an angiogram was performed before the selection
of the endograft, with the tip of the centimeter-scale pigtail catheter located
at the aortic leaflets. The angiographic measurements confirmed the CT
angiographic findings and provided the final measurements of the length
of the ascending aorta and the distance from the aortic valve to the lesion.
They also confirmed aortic valve competency and the patency of the
supra-aortic vessels and any previously performed carotid–carotid bypass.
Patients with an entry tear located in the distal third of the ascending
aorta underwent carotid–carotid bypass graft to increase the length of the
landing zone and avoid cerebral ischemia before deployment of the
endograft. This procedure was not needed in the patients with the lesion
in the middle third of the ascending aorta, because the distal landing
zone of the endograft did not compromise the supra-aortic branches in
these patients.
A super-stiff Lunderquist guidewire was positioned using fluoro-
scopic guidance, with its floppy tip inside the left ventricle. The selected
endograft and delivery system were delivered into the ascending aorta.
In devices with long tips (eg, Medtronic, Minneapolis, Minn; Cook
Medical, Bloomington, Ind), the nose cone was positioned across the
aortic valve, after the induction of hypotension (about 60 mm Hg)
with nitroprusside, allowing careful control of the guidewire and
avoidance of cardiac trauma. In devices with short tips (eg, Gore,
W. L. Gore & Associates, Flagstaff, Ariz), it was not necessary to cross
the nose cone through the aortic valve into the left ventricle, and the tip
of the device remained at the level of the valve. The device was then
deployed quickly to avoid dislodgement by hemodynamic forces and/or
transient ventricular arrhythmias. A completion angiogram was used to
confirm exclusion of the lesion, competency of the aortic valve, patency
of the coronary arteries, patency of the supra-aortic vessels and the
carotid–carotid bypass graft, when applicable, and to evaluate the distal
aorta. The patients were allowed to recover after the procedure. On the
evening before the day of discharge, all patients underwent postoperative
CT angiography.
The medical records were retrospectively reviewed after institutional
review board approval. The information collected included patient
demographics, individual characteristics, risk factors, comorbidities, com-
plications, and final clinical outcomes. Patients were followed up at regular
intervals as allowed by the Brazilian public health system—generally
yearly, including follow-up with regular clinical examinations and
CT angiograms, as needed.RESULTS
Of the 8 high-risk patients with acute and complicated
type A aortic dissection, 7 agreed to participate in the
present study. The clinical and demographic data from these
patients at their acute presentation are listed in Table 1.
Of the 7 patients, 3 were men and 4 were women, with a
mean age of 59.1  7.7 years and mean body mass index
of 22.8  3.9 kg/m2. They were considered high riskery c July 2014
TABLE 1. Demographics and clinical data
Pt. no. Gender Age (y) BMI (kg/m2) HTN CAD MI Smoking COPD DLP ASA
1 Male 71 21.7 Yes Yes No Yes Yes No 3
2 Male 57 20.5 Yes Yes No Yes No Yes 3
3 Male 52 24.5 No No No Yes Yes No 3
4 Female 71 24.8 Yes Yes No No No No 3
5 Female 48 23.1 Yes Yes Yes No No No 3
6 Female 57 21.6 Yes Yes No Yes No No 3
7 Female 58 23.2 Yes Yes No No No Yes 3
Pt. no., Patient number; BMI, body mass index; HTN, systemic arterial hypertension; CAD, coronary artery disease; MI, myocardial infarction; COPD, chronic obstructive
pulmonary disease; DLP, dyslipidemia; ASA, American Society of Anesthesiologists (classification).
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chronic obstructive pulmonary disease (patients 1 and 3),
severe coronary artery disease (patients 2, 4, 5, and 6),
and previous cardiopulmonary bypass (patient 7). None of
the patients had diabetes, elevated creatinine (>2 mg/mL),
peripheral arterial disease, previous cerebrovascular
symptoms, or cancer. The preoperative details, operative
data, and acute in-hospital course of these patients are listed
in Table 2. Of these 7 patients, 4 had penetrating aortic
ulcers at the ascending aorta, 2 had acute type A dissections,
and 1 had chronic dissection and aneurysmal degeneration
of the distal ascending aorta and arch. The average
maximum aortic diameter was 74 mm (range, 44-110),
the average proximal neck diameter was 31 mm (range,
25-38), and the average distal neck diameter was 29 mm
(range, 25-34). The endograft diameters ranged from
31 to 44 mm. The technical success rate was 87%, with
1 intraoperative death.
The proximal landing zone was located in the proximal
third of the ascending aorta in all patients and ranged
from<10 to 27mm (average, 21) above the aortic valve. Pa-
tients 1, 3, and 7 underwent placement of a carotid–carotid
bypass graft before the endovascular procedure because
the lesion was located in the distal third of the ascending
aorta, potentially compromising the supra-aortic branches.
Patients 2, 4, 5, and 6 did not require any predeployment
intraoperative procedures, because the entry tear was
located in the middle third of the ascending aorta.
Figure 1 shows the typical treatment of a penetrating ulcer
located in the middle third of the ascending aorta.
The distal landing zone was at zone 0 in 4 patients
(patients 2, 4, 5, and 6), with a mean distance of 7.7 mm
(range, 2-21) proximal to the innominate artery. In 3
patients, the distal landing zone was more distal (patients
1, 3, and 7). The distal landing zone of patient 3 should
have been in zone 1, because he presented with a
penetrating ulcer at the distal third of the ascending aorta
that reached the innominate artery. His treatment was
intended to cover the innominate artery ostium, requiring
left-to-right carotid–carotid bypass. However, after
endograft deployment, the left carotid artery was noted to
be occluded. Stenting the left carotid artery intraoperativelyThe Journal of Thoracic and Causing the chimney technique restored both carotid and
cerebral flow, and the distal landing zone was in zone 2
(3 mm distal to the left carotid artery).
The distal landing zone of patients 1 and 7 was in zone
4 (101 and 178 mm below the left subclavian artery,
respectively), with their arch and the supra-aortic ostia
completely covered by the endografts. Patient 1 had 2
penetrating aortic ulcers; the first was located at the distal
third of the ascending aorta close to innominate artery
and the second was distal to the left subclavian artery.
Thus, intraoperatively, he underwent a right-to-left ca-
rotid–carotid bypass; through the right carotid incision, a
16 3 95-mm Medtronic limb extension was placed into
the ascending aorta, 27 mm above the aortic valve, using
the periscope technique. Thereafter, 2 thoracic Medtronic,
42 3 42 3 150-mm and 44 3 44 3 200-mm, endografts
were delivered 15 mm above and parallel with the limb
extension, covering the aortic arch and its branches, and
landing distally 101 mm below the left subclavian artery,
excluding the 2 penetrating aortic ulcers with pseudoaneur-
ysm formation. Cerebral flow was maintained by the limb
extension and carotid–carotid bypass (Figure 2). Patient 7
was the only patient who did not require emergency treat-
ment. She had been previously undergone surgery 5 years
earlier with conventional open repair for an acute type A
dissection. She had eventually developed an arch aneurysm
and chronic dissection of the descending and abdominal
aorta, beginning at the distal third of the ascending aorta,
just distal to the previously placed tube graft. She presented
with chest discomfort and hoarseness. She underwent the
same procedure as patient 1, with cervical debranching
and a 16 3 95-mm Medtronic limb extension placed into
the ascending aorta 17 mm above the aortic valve and 2
thoracic 36 3 36 3 200-mm Medtronic endografts placed
to cover the aortic arch and its branches, landing distally
178 mm below the left subclavian artery.
Patient 4 developed acute aortic insufficiency immedia-
tely after deployment of the endograft because of arrest of
the noncoronary leaflet of the aortic valve by the distal
bare stent ring. She underwent immediate conversion to
open surgery with cardiopulmonary bypass but did not
survive.rdiovascular Surgery c Volume 148, Number 1 107
TABLE 2. Preoperative, intraoperative, and in-hospital postoperative data
Patient 1 2 3 4 5 6 7
Indication for
intervention
Penetrating ulcer in
distal third of AA
Penetrating
ulcer in
middle third
of AA
Penetrating
ulcer in
distal third
of AA
Penetrating
ulcer in
middle third
of AA
Type A
dissection
in middle
third of AA
Type A
dissection
in middle
third of AA
Arch aneurysm
and chronic
dissection in
distal third of
AA and arch
Maximum aortic
diameter (mm)
72 44 59 64 110 87 82
Proximal neck (mm) 38 25 30 30 26 37 31
Distal neck (mm) 34 26 25 30 28 32 27
Devices (mm) Medtronic Valiant
42 3 150 mm
þ 44 3 200 mm
TAG Gore
31 3 100 mm
TAG Gore
40 3 100 mm
Medtronic
Valiant
36 3 70 mm
Zenith Cook
32 3 80 mm
TAG Gore
40 3 100 mm
Medtronic Valiant
36 3 36 200 mm
þ 36 3 36 3
200 mm
Proximal landing
zone (distance
from sinotubular
junction; mm)
5 3 1 NA* 7 3 9
Distal landing zone Zone 4 (101 mm
distal to LSA)
Zone 0 (6 mm
proximal
to IA)
Zone 2
(3 mm distal
to LCC)
Zone 0 (21 mm
proximal
do IA)
Zone 0 (2 mm
proximal
to IA)
Zone 0 (2 mm
proximal
to IA)
Zone 4 (178 mm
distal to LSA)
Predeployment
intraoperative
procedures
Right–left carotid–
carotid bypass
þ IA chimney
with 16 3 95-mm
endograft
No Left–right
carotid–carotid
bypass
No No No Right–left carotid–
carotid bypass þ
IA chimney with
16 3 95-mm
endograft
Intraoperative
complications
No No LCA occlusion Acute aortic
insufficiency
Endoleak 1B No No
Additional
intraoperative
postdeployment
procedures
No No LCA stenting
(bare)
Conversion to
open surgery
Deployment
of another
Zenith Cook
device
36 3 77 mm
No No
Postoperative
in-hospital
complications
Pneumonia No No Death Pneumonia Pulmonary
embolism
Endoleak type 1,
corrected with
another device
extension
AA, Ascending aorta; IA, innominate artery; NA, not available; LCA, left carotid artery; LSA, left subclavian artery; LCC, left common carotid artery. *Unable to be measured
postoperatively because of patient course.
Acquired Cardiovascular Disease Bernardes et al
A
C
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ment procedures. Patient 5 required an additional distal
endograft to treat a type 1B distal endoleak, with excellent
angiographic results (Figure 3).
Patients 1, 2, 6, and 7 and did not have any intraoperative
complications.
Three patients developed in-hospital postoperative
pulmonary complications. Patients 1 and 5 developed
pneumonia, and patient 6 developed a pulmonary embo-
lism. However, all were discharged without any additional
symptoms. Patient 7 developed an in-hospital postoperative
type 1A endoleak due to migration of the limb extension;
this was asymptomatic and was diagnosed from the
predischarge CT angiogram. It was corrected with deploy-
ment of another 16-mm limb extension the next day.108 The Journal of Thoracic and Cardiovascular SurgDuring a mean follow-up of 26.3 months (range,
3.5-55.5), all 6 surviving patients remained alive
(Table 3). Two repeat aortic dissections with evidence
of hemorrhage occurred an average of 2 months after
endovascular treatment. Both patients (patients 5 and
6) were those who had initially presented with acute
type A dissection at the middle third of the ascending
aorta. The repeat dissections were at the distal edge of
the endograft. These patients were treated with open
surgery and cardiopulmonary bypass; both survived.
Patient 5 had residual mild renal insufficiency not
requiring dialysis, and patient 6 had residual mild
dyspnea. No patient presented again with an acute
aortic syndrome or other referable symptoms during
the follow-up period.ery c July 2014
FIGURE 1. Treatment of an ascending aortic penetrating ulcer. A, Computed tomography scan and (B) angiogram showing a penetrating ulcer at the
ascending aorta. C, Positioning the thoracic endovascular aneurysm repair device between the ostia of the coronary arteries and the innominate artery.
D, Postdeployment angiogram depicting technical success. White arrow indicates right coronary artery; black arrow, innominate artery.
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Conventional surgery remains the reference standard for
acute aortic syndromes in the ascending aorta. However,
28% of these patients will be considered unfit for open
repair.6 After several published reports demonstrated the
feasibility of endovascular repair of the ascending aorta in
patients with high surgical risk, we began to offer endo-
vascular treatment to very selected high-risk patients with
acute ascending aortic syndromes.5-9 Endovascular repair
has emerged as a potential alternative to emergency open
surgical repair for acute aortic syndromes in selected
patients.6,8,10-13 The feasibility of endovascular ascending
aortic repair has been demonstrated in several case reports
that used a variety of devices, all originally designed
for the descending aorta.1,2,4,5,7-9 Recently, the use of a
novel endograft designed for the ascending aorta was
successfully reported; however its mid- and long-termThe Journal of Thoracic and Caresults are unknown.3,6,8 Beyond these few reports, the
current data are still sparse.
Several challenges exist to endograft placement in the
ascending aorta because of the proximity of the coronary
arteries, aortic valve, and supra-aortic branches. Thus, the
selection criteria for endovascular repair in zone 0 requires
suitable anatomy, such as our inclusion criteria: proper land-
ing zones, absence of aortic valve insufficiency, and an entry
tear site at least 1.5 cm above the aortic valve (see the
‘‘Methods’’ section). It has been reported that only 32% of
patients with acute type A syndromes will have anatomy
suitable for endovascular approaches to the ascending
aorta.4 In the present report, the proximal landing zone
was an average of 20.7 mm above the aortic valve, similar
to previous reports (20-25 mm above the aortic valve).6
The length of the ascending aorta is another limitation
to endovascular treatment of zone 0 pathologic features.rdiovascular Surgery c Volume 148, Number 1 109
FIGURE 2. A, Diagram of patient 1’s procedure. B, Completion computed tomography angiogram, with 3-dimensional reconstruction, showing the
technical success.
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about 80 to 90 mm long. However, in patients with acute
syndromes and aneurysmal formation, the length has
usually increased. This increase was the critical reason for
our careful measurement with an intraoperative angiogram
before selection of the endograft. The devices deployed inFIGURE 3. Completion angiography in 1 patient with type A dissection
treated with 2 thoracic endovascular aneurysm repair devices. The second
device was placed because of an endoleak at the distal landing zone close
to the innominate artery. White arrow indicates right coronary artery;
black arrow, innominate artery.
110 The Journal of Thoracic and Cardiovascular Surgthe ascending aorta for lesions in its middle third ranged
from 70 to 100 mm, and those deployed for lesions in its
distal third ranged from 100 to 200 mm; all lesions in the
distal third of the ascending aorta underwent cervical
debranching to extend the landing zones and preserve
supra-aortic branch perfusion.
Treatment of zone 0 can also be complicated by
negotiation of the device around the curvature of the aortic
arch, the need to ensure good proximal fixation close to the
aortic valve and precise distal fixation close to the
supra-aortic vessels, the large hemodynamic forces that
can cause endograft migration, placement of a stiff
guidewire inside the left ventricle with the potential for
perforation and exsanguination, and stiff device tips with
the potential for fatal retrograde dissection. These technical
challenges are both inherent to the location of zone 0 and
also reflect the current generation of devices, conferring
considerable risk and preventing easy dissemination of
the procedure, despite its minimally invasive nature.6,10
Previously published cases have reported similar serious
complications, including massive embolic stroke and
ventricular perforation by the stiff guidewire and aortic
valve insufficiency due to dilatation of the aortic ring by
an oversized endograft.3,10 Despite our complications, no
strokes and no ventricular damage were seen, with an
overall technical success rate of 87% (6 of 7). Of the
cases of penetrating aortic ulcers, we had a mortality rate
of 25% (1 of 4). The mortality for open repair of these
lesions has ranged from 18% to 60% in the acute setting.3
During follow-up, we observed 2 early (average,
2 months) aortic ruptures, both of which occurred inery c July 2014
TABLE 3. Follow-up and outcomes after endograft placement in the ascending aorta
Pt. no. Follow-up (mo) Aortic rupture
Aortic complication
treatment
Reintervention-free survival
(mo) Current status
1 10.0 No NA 10.0 Alive, asymptomatic
2 55.5 No NA 55.5 Alive, asymptomatic
3 18.0 No NA 18.0 Alive, mild dyspnea
4 0 No NA 0 Dead
5 46.4 Yes Open surgery 2.2 Alive, CRF
6 24.5 Yes Open surgery 1.7 Alive, mild dyspnea
7 3.5 No NA 3.5 Alive, asymptomatic
Pt. no., Patient number; NA, not applicable; CRF, chronic renal failure.
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dissection. Thus, both of these complications were actually
repeat dissections complicated by rupture at the edge of the
endograft distal landing zone. Each of these complications
was treated with emergency open surgery, although the
patients had at first been categorized as high risk by a
multidisciplinary team. Both patients had severe coronary
artery disease. Patient 5 had experienced a previous
myocardial infarction, and patient 6 had multivessel disease
with a previous left ventricular ejection fraction of 38%.
The outcome of the open surgery resulted in patient survival
without major complications, probably owing to better
medical treatment of the condition that was not present at
the first presentation. We interpreted the ruptures as
resulting from the dynamic and unstable nature of aortic
dissection that caused an unfavorable interaction between
the diseased aorta and the endograft. However, Lu and
colleagues,6 in China, reported good results for 15 patients
with acute type A dissections treated with specifically
designed devices for the ascending aorta. They reported 1
repeat dissection (6.6%) after 3 months of follow-up.
Ronchey and colleagues,3 in Italy, reported a 50% repeat
dissection rate (2 of 4 patients) after 3 months; the
remaining 2 patients had persistent patent false lumens.
The use of nondedicated, off-the-shelf devices is probably
a not good indication for acute type A dissections. Accord-
ingly, we recommend close follow-up of these patients.
Of our 7 patients, 4 had excellent outcomes; all were
patients with penetrating ulcers who presented with
localized pseudoaneurysms or chronic dissection with
aneurysm formation. It is possible that these were more
stable lesions compared with acute dissection. After an
average follow-up of 22 months (range, 3.5-55.5) for these
4 patients, each patient was alive, with no additional
symptoms, no supra-aortic branch occlusion, no aortic
diameter growth, and no endoleaks.
The present study had some limitations. Despite deploy-
ment of all endografts in the proximal landing zone of the
ascending aorta (zone 0), we treated a heterogeneous group
of aortic syndromes. Some pathologies, such as penetrating
ulcers and chronic dissections, were more stable than
others, such as acute dissections, leading to different resultsThe Journal of Thoracic and Cafor the different pathologies. In addition, zone 0, the
ascending aorta, is not a homogeneous anatomic segment.
It requires different strategies to approach each of its
segments. The proximal third of this segment is
unapproachable using endovascular treatment with the
current technology when the aortic valve and coronary
arteries are also involved. Future technology, perhaps
requiring a combination of transcatheter aortic valve
implantation and endovascular aneurysm repair technolo-
gies, should be able to treat this segment. The middle third
is currently the best anatomic site for performing a purely
endovascular repair.3,6,8 The distal third, owing to the
proximity to supra-aortic branches, frequently requires a
hybrid approach.9,10,14-19
CONCLUSIONS
Endovascular treatment of the ascending aorta is feasible
with commercially available descending thoracic endo-
grafts in selected categories of patients with suitable
anatomy. It might be an acceptable alternative to open
repair because of the reduced associated risks in a very
select subgroup of high-risk patients. Acute dissections,
although anatomically suitable, seem to be more unstable
after treatment and might represent a group that would be
better approached with dedicated devices. In patients
with penetrating aortic ulcers or degenerative aneurysmal
formation, good mid-term results can be obtained with
current endovascular devices. Additional research is
mandatory, and the refinement of devices could allow
improved treatment of all ascending aorta pathologic
entities.
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